Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Wednesday 01 May, 2019

Winchester MD Ltd

WEBSITE LAUNCH - Replacement

RNS Number : 6583X
Winchester MD Limited
30 April 2019
 

The headline for the Winchester MD announcement released on 30 April 2019 at 07:00 under RNS No 4851X should read:

WINCHESTER MD LAUNCHES REDESIGN OF HEMP ELF CBD RETAIL WEBSITE and WINCHESTER MD WEBSITE

LONDON, April 30, 2019  - WINCHESTER MD LIMITED ("Winchester" or the "Company") is pleased to announce that the Company launched a full redesign of their Hemp Elf on-line CBD Wellness site and can be accessed at www.hempelf.com.

 

Faz Moshfeghi, CEO of Winchester MD, comments on the history and background of Winchester "15 months ago HempElf was created (www.hempelf.com) out of the idea to bring professionalism and quality to the cannabis industry in the UK and through-out Europe. My son Marti approached me with the idea of procuring and fulfilling CBD products in the UK market. I initially had my doubts about cannabis - like most people in UK - but because of Marti's passion and after extensive research I decided to support my son and we teamed up to launch HempElf.  What we learnt early on in our journey was that many CBD businesses were in a rush to make products without really paying any attention to the aesthetics, looks and taste of their products. They were focused on quoting large CBD percentages and claim that because their product had CBD, it was justifiable to have a strong bitter taste. We realised from the outset that quality and reliability should be major considerations when selecting products and we set about sampling as many products available on the market as possible and by Feb 2018 we had selected our initial range of products. HempElf was launched as an online store, operated by Winchester MD Limited (formerly Green Biosciences) and offering 15 products. 12 months later we have over 100 products for sale in our online store with monthly sales in excess of 25,000 orders and 45,000 online visitors per month. We have been voted as UK's No 1 supplier of quality CBD flowers by two of the industry publication CBDTesters and High&Polite and have built a customer base of more than 10,000 loyal followers. Throughout this time we have remained true to our founding principles of Quality, Reliability and Transparency and our trading name HempElf.com has become synonymous with high quality products. Winchester is one of the first CBD companies in the UK to successfully put in place credit card handling facilities and simplify the customer shopping experience. In February 2019 we secured a strategic partnership with High Standard Capital from Vancouver, operated by Dan Kriznic - former CEO of Invictus MD (TSXV:GENE) (one of Canada's early entrants into the legal cannabis space) and a pioneer in the cannabis space owning and operating cannabis assets in Canada, United States, Jamaica, Peru, Mexico and now Europe. We continue to look for new products for HempElf based on customer demand and also plan on introducing our own branded products".

 

 

For more information, please visit www.winchestermd.com

 

On Behalf of the Board,

Farzad Moshfeghi

CEO

[email protected]

 

About Winchester MD Limited

 

Winchester is a vertically integrated European cannabis company based out of London, UK. The Company was founded in 2018 with an initial focus on CBD Wellness through a revenue producing online retail platform Hemp Elf www.hempelf.com. The Company offers a variety of CBD products through its on line store and continues to develop and market new products in the CBD Wellness category. In 2019 the Company has expanded into other verticals in the cannabis sector including with the vision of becoming a global cannabis leader with cultivation, extraction, CBD wellness, R&D and clinics/education

 

 

Cautionary Note Regarding Forward-Looking Statements: This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, timing, assumptions or expectations of future performance, including that the Company is anticipated to enter into a definitive agreement with Winchester by April 15, 2019 and Winchester will manufacture and distribute CannAmerica branded CBD infused products in Europe are forward-looking statements and contain forward-looking information. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or "occur". Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including that the Company will be successful in entering into a definitive agreement with Winchester by April 15, 2019 and Winchester will successfully manufacture and distribute CannAmerica branded CBD infused products in Europe. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, the Company will not be successful in entering into a definitive agreement with Winchester by April 15, 2019 and Winchester will not be able to manufacture and distribute CannAmerica branded CBD infused products in Europe. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.

 

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
NRADBGDSSUXBGCG

a d v e r t i s e m e n t